At what enterprise value was MYDENTIST acquired in 2025?

During the acquisition of MYDENTIST by BRIDGEPOINT in 2025, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b GBP. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 15.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of MYDENTIST when it was acquired by BRIDGEPOINT?

The estimated EV/EBITDA multiple for MYDENTIST is in the range of 10x - 18x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 15.6x. Join our community for free to access full valuation data and industry trends.

When was MYDENTIST acquired by BRIDGEPOINT?

MYDENTIST was acquired by BRIDGEPOINT in 2025.

What was the revenue of MYDENTIST at the time of the deal?

The revenue of MYDENTIST at the time of the deal is estimated to be in the range of 450M - 900M GBP. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of MYDENTIST during the acquisition?

MYDENTIST's EBITDA is estimated to be in the range of 50M - 100M GBP. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the MYDENTIST acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the MYDENTIST deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://samera.co.uk/bridgepoint-acquires-mydentist/

← DATABASE

Home Database Healthcare & PharmaMYDENTIST

07/2025

MYDENTIST acquired by BRIDGEPOINT

UNITED KINGDOM Health Providers / Outpatient Care / Dental Centers EV 500M - 1.5b GBP

Context

Bridgepoint acquired MyDentist from its long-term owners (likely Palamon Capital Partners and The Carlyle Group). Bridgepoint aims to accelerate the group's pivot from low-margin NHS contracts toward high-growth private treatments (implants, aesthetics, clear aligners). Leveraging its prior success with Oasis Dental Care, Bridgepoint plans to implement a rigorous operational efficiency program, utilizing digitalization and AI to optimize chair utilization and patient triage. Furthermore, MyDentist will serve as a consolidation platform, aggressively acquiring smaller independent practices to realize economies of scale in a fragmented market.

MYDENTIST, which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

MyDentist is the largest network of dental practices in the UK, operating approximately 600 clinics. The group provides both NHS and private dental care to millions of patients. Historically known for its heavy exposure to NHS contracts, the group has been aggressively pivoting toward higher-margin private treatments (cosmetic, implants, clear aligners) to combat stagnant government funding.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (GBP)

Year

Rev

EBITDA

EBIT

2024

2023

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
11/2025	METRIC CAPITAL PARTNERS	EXCELLENCE IMAGERIE	FRANCE	Radiology
10/2025	GROUPE RESONANCE IMAGERIE	CIMEP	FRANCE	Radiology
05/2025	FONDATION SANTE SERVICE	CLARIANE HAD (HOME HOSPITALIZATION SERVICES)	FRANCE	Outpatient Care
04/2025	EUROFINS SCIENTIFIC	SYNLAB SPAIN	SPAIN	Labs (Biology)
12/2024	SONIC HEALTHCARE	LADR – LABORATORY GROUP DR. KRAMER & COLLEAGUES	GERMANY	Labs (Biology)
12/2024	CAPZA	IMDEV	FRANCE	Radiology
11/2024	GROUPE IMAGERIE CARDINET	RADIOLOGIE PARIS OUEST	FRANCE	Radiology
11/2024	WELLTOWER	CARE UK	UNITED KINGDOM	Nursing Homes
10/2024	ARDIAN	VISTA VISION	ITALY	Ophthalmology
10/2024	MONTEFIORE INVESTMENT	DEMENEGO	ITALY	Ophthalmology

REFERENCES

Valuation range: EV 500M - 1.5b GBP

Revenue range: 450M - 900M GBP

EBITDA range: 50M - 100M GBP

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of MYDENTIST by BRIDGEPOINT are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: mydentist

Acquirer: bridgepoint